MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-20-2026
IDEXX Laboratories Current Ratio 2011-2026 | IDXX
Annual Current Ratio IDEXX Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.92 | 1.94 | 1.84 | 1.28 | 1.39 | 1.38 | 0.937 | 0.849 | 0.968 | 0.905 | 0.959 | 0.925 | 1.36 | 1.4 | 1.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.94 | 0.849 | 1.28 |
Quarterly Current Ratio IDEXX Laboratories
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.86 | 1.78 | 1.82 | 1.94 | 1.93 | 1.86 | 1.88 | 1.84 | 1.73 | 1.62 | 1.43 | 1.28 | 1.22 | - | 1.33 | 1.39 | 1.46 | 1.45 | 1.43 | 1.38 | 1.38 | 1.38 | 1.38 | 1.11 | 1.11 | 1.11 | 1.11 | 0.99 | 0.99 | 0.99 | 0.99 | 0.97 | 0.97 | 0.97 | 0.97 | 0.93 | 0.93 | 0.93 | 0.93 | 0.95 | 0.95 | 0.95 | 0.95 | 1.09 | 1.09 | 1.09 | 1.09 | 1.73 | 1.73 | 1.73 | 1.73 | 2.36 | 2.36 | 2.36 | 2.36 | 2.1 | 2.1 | 2.1 | 2.1 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.36 | 0.93 | 1.44 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
7.55 | $ 2.91 | 2.83 % | $ 94.4 K |  USA |
 |
Agilent Technologies
A
|
2.01 | $ 120.6 | 1.35 % | $ 36.7 B | USA |
 |
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
1.63 | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
5.26 | $ 22.99 | -2.36 % | $ 241 M |  China |
 |
Castle Biosciences
CSTL
|
7.05 | $ 28.29 | 2.59 % | $ 786 M | USA |
 |
Celcuity
CELC
|
1.89 | $ 110.26 | 2.66 % | $ 4.35 B | USA |
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
13.4 | $ 14.17 | 2.76 % | $ 428 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M |  Britain |
 |
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
1.82 | $ 179.36 | 2.09 % | $ 8.89 B | USA |
 |
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
6.69 | $ 130.32 | 0.59 % | $ 20.7 B | USA |
 |
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | China |
 |
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 281.71 | -0.48 % | $ 23.4 B | USA |
 |
Lantheus Holdings
LNTH
|
1.96 | $ 77.76 | -1.37 % | $ 5.25 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | USA |
 |
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K |  Israel |
|
Biodesix
BDSX
|
1.27 | $ 15.22 | -1.81 % | $ 1.97 B | USA |
 |
Mettler-Toledo International
MTD
|
0.994 | $ 1 301.87 | -1.13 % | $ 26.8 B |  Schweiz |
 |
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | USA |
 |
Myriad Genetics
MYGN
|
2.09 | $ 5.37 | 1.51 % | $ 497 M | USA |
 |
NeoGenomics
NEO
|
2.6 | $ 9.28 | -2.73 % | $ 1.19 B | USA |
 |
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M | USA |
 |
National Research Corporation
NRC
|
1.67 | $ 13.21 | -1.34 % | $ 324 M | USA |
 |
BioNano Genomics
BNGO
|
1.86 | $ 1.14 | 2.0 % | $ 1.45 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.25 | $ 208.57 | 0.1 % | $ 23.2 B | USA |
 |
Danaher Corporation
DHR
|
5.19 | $ 204.44 | 0.21 % | $ 146 B | USA |
 |
Organovo Holdings
ONVO
|
3.52 | - | -2.3 % | $ 19.4 M | USA |
 |
OPKO Health
OPK
|
2.64 | $ 1.2 | 0.84 % | $ 833 M | USA |
 |
Exact Sciences Corporation
EXAS
|
1.69 | $ 103.47 | 0.09 % | $ 19.5 B | USA |
 |
Bioventus
BVS
|
1.37 | $ 8.56 | -2.06 % | $ 536 M | USA |
 |
Pacific Biosciences of California
PACB
|
1.01 | $ 1.59 | 4.56 % | $ 477 M | USA |
 |
DarioHealth Corp.
DRIO
|
4.85 | $ 9.67 | -6.12 % | $ 274 M | Israel |
 |
DexCom
DXCM
|
1.76 | $ 73.24 | 0.22 % | $ 28.6 B | USA |
 |
PerkinElmer
PKI
|
2.47 | - | -0.91 % | $ 14.7 B | USA |
 |
Psychemedics Corporation
PMD
|
2.18 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
4.93 | $ 26.37 | 5.57 % | $ 34.2 M | USA |
 |
QIAGEN N.V.
QGEN
|
1.88 | - | - | $ 10.6 B |  Niderland |
 |
Personalis
PSNL
|
4.02 | $ 8.79 | 1.38 % | $ 521 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.29 | $ 109.93 | 1.13 % | $ 9.07 B |  Irlanda |
 |
Quotient Limited
QTNT
|
0.861 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Renalytix AI plc
RNLX
|
0.504 | - | 5.66 % | $ 22.7 M | Britain |
 |
CareDx, Inc
CDNA
|
3.75 | $ 19.25 | 2.39 % | $ 1.03 B | USA |